Study to Assess the Safety, Tolerability and Efficacy of Bilastine Ophthalmic Solution 0.6% in Children

Condition:   Allergic Conjunctivitis Interventions:   Drug: Bilastine;   Drug: Placebo Sponsors:   Faes Farma, S.A.;   Dynamic Science S.L. Not yet recruiting

Source: ClinicalTrials.gov - March 23, 2021 Category: Research Source Type: clinical trials